A. Teplyakov
with Gilliland · 2010–2019
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from A. Teplyakov's perspective
Ordered by how strongly the researchers A. Teplyakov trusts endorse each paper. Same corpus, a different order for every researcher.
- Computational design of antibody-affinity improvement beyond in vivo maturation (Nature Biotechnology)
- MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
- Blind prediction performance of RosettaAntibody 3.0: Grafting, relaxation, kinematic loop modeling, and full CDR optimization
- Engineered antibody Fc variants with enhanced effector function.
- Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange (Science)
- Critical assessment of methods of protein structure prediction—Round VII
- MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes (Nucleic Acids Res.)
- Proteins
- Structure-Function of the G-protein-Coupled Receptor Superfamily (Annual Review of Pharmacology and Toxicology)
- Immunogenicity of engineered antibodies. (Methods)
Their papers
- Antibody modeling assessment (2011) — 118 citations
- Antibody modeling assessment II. Structures and models (2014) — 58 citations
- Antibody Structure and Function: The Basis for Engineering Therapeutics (2019) — 501 citations
- Design of novel FN3 domains with high stability by a consensus sequence approach. (2012) — 75 citations
- Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab. (2010) — 111 citations